Akums Drugs and Pharmaceuticals

Listing Details
BSE : 544222 | NSE : AKUMS
Industry : Pharma Formulations | ISIN : INE09XN01023 | FreeFloat : 10.00% | FnO : No | LotSize : N/A
Indices containing this Stock
Nifty Smallcap 250
Valuation (Rs. Cr)
Intellectual Capital (IC)1,772.87
Net Worth (NW)2,860.46
Intrinsic Worth (IW)4,633.33
Market Cap (MC)13,155.78
Economic Value Added0.49
Assumptions
Discount Rate%
Liquidity Premium%
IC Ratios
Knowledge Basis (IC/IW)38.26%
IC Gross Margin (EBITDA/IC)30.18%
IC Net Margin (NPT/IC)19.19%
Knowledge Turnover (Sales/IC)2.30
Market to Intrinsic Value (MC/IW)2.84
Stock Price
As OfIntrinsic ValueMarket Price
30 Sep 2024Rs. 294.38Rs. 835.85
3 Dec 2024 ---- Rs. 623.45
4.75     0.76%
Stock Sentimeter
Fundamental - QualityTechnical - Daily Price actionNear-term Outlook
EVA > 0 : YesBearish10 DMA : Rs. 623.79AccumulationFairly Bearish
KB > 50% : No50 DMA : Rs. 786.93
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Sentimeter is based on market data caclulations and is NOT an investment advice

Question 3 - Is this stock undervalued?

Intrinsic Value v/s Book Value v/s Market Price over Time

Question 2 - Does this business have significant knowledge assets?

Knowledge Basis over Time

Question 1 - Is this business generating enough profits to cover its cost of capital?

EVA® over Time
* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-23
C
969.89
977.98
-117.18
-146.89
-159.04
-187.43
-187.75
Sep-23
C
1181.25
1188.03
158.61
128.19
114.53
32.69
32.61
Dec-23
C
1082.77
1091.75
102.35
70.80
58.36
195.00
191.35
Mar-24
C
944.21
954.45
13.23
-20.72
-33.10
-39.47
-39.09
Jun-24
C
1019.11
1025.66
134.56
100.50
87.48
61.21
61.84
Sep-24
C
1033.09
1046.56
134.66
99.79
87.89
66.65
65.77
* C - Consolidated, S - Standalone

Standard Disclaimer

  1. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
  2. Past performance, by way of backtesting or by way of actuals, is no guarantee of future returms.
  3. Data mentioned on this page is for educational purpose only and does not constitute investment advice.
Standard Warning - Investment in securities markets are subject to market risk. Read all the related documents carefully before investing.